Piramal Life on i-pill buyout

  • 9:51
  • Published On: March 25, 2010
Cinema View
Embed
Swati Piramal, a director of Piramal Life Sciences, said the i-pill buyout fits well with its OTC range and "we think we can bring value and growth" to the product.

Related Videos

Sensex Drops Over 300 Points Ahead Of RBI Monetary Policy Decision
February 05, 2025 1:40
Budget 2025: What’s In It for You?
January 30, 2025 19:46
Madhya Pradesh CM Mohan Yadav Receives Warm Welcome in Japan, Seeks Boost In Trade And Investment
January 28, 2025 1:27
"India Emerging As Exciting Location For Businesses": Anant Goenka At Davos
January 24, 2025 4:40
Chhattisgarh Secures Rs. 6,000 Crore in Investment Proposals at Investor Connect Meet
January 23, 2025 1:11
Over 50 Lakh Devotees At Ayodhya Ram Mandir Give Economic Boost
January 22, 2025 1:59
What's Next For Fusion Power And AI? 3 Business Leaders Explain At Davos
January 19, 2025 8:06
LA Wildfires: At Least 10 Killed | Canada: Liberal Party To Choose New Leader On March 9
January 10, 2025 9:47
Japan’s Nippon Steel | National Security Being Used As A Power Move In Nippon Steel’s Rejection?
January 07, 2025 2:28
Italy Plans $1.6 Billion Spacex Telecom Deal: Report
January 06, 2025 1:55
NDTV's Emerging Business Conclave: Experts Discuss Building A Workforce Ready For The Future
December 29, 2024 21:46
Record Producer Richard Perry Dies At 82 | Beyoncé Perform During Xmas Gameday| The World Report
December 26, 2024 0:30